- dsm-firmenich Q1 2024 trading update
- Progress on share repurchase program to cover share plans
- dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans
- dsm-firmenich announces repurchase of 1.5m shares to cover share plans
- Ad Hoc Press Release - Regulated Information
- dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China
- dsm-firmenich publishes 2023 Integrated Annual Report
- dsm-firmenich to separate out Animal Nutrition & Health business from the Group
- dsm-firmenich reports full year 2023 results
- dsm-firmenich completes voluntary cash offer for DSM shares
More ▼
Key statistics
As of last trade DSM-Firmenich AG (DSFIR:AEX) traded at 103.70, -14.06% below its 52-week high of 120.66, set on May 12, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 104.00 |
---|---|
High | 105.05 |
Low | 102.75 |
Bid | 103.70 |
Offer | 103.75 |
Previous close | 103.75 |
Average volume | 601.56k |
---|---|
Shares outstanding | 265.68m |
Free float | 66.89m |
P/E (TTM) | -- |
Market cap | 27.56bn EUR |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 03 2024 11:11 BST.
More ▼